Welcome to LookChem.com Sign In|Join Free

CAS

  • or

38068-98-3

Post Buying Request

38068-98-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38068-98-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 38068-98-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,0,6 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 38068-98:
(7*3)+(6*8)+(5*0)+(4*6)+(3*8)+(2*9)+(1*8)=143
143 % 10 = 3
So 38068-98-3 is a valid CAS Registry Number.

38068-98-3Relevant articles and documents

Kinetics and Mechanism of Pyrrolidine Buffer-Catalyzed Fulvene Formation

Sieverding, Paul,Osterbrink, Johanna,Besson, Claire,K?gerler, Paul

, p. 486 - 494 (2019/01/11)

Rapid synthesis of fulvenes is achieved using pyrrolidinium/pyrrolidine buffers in anhydrous acetonitrile. Time-dependent UV-vis absorption and NMR spectroscopy reveal that the rate and yield of fulvene formation depend strongly on both the presence of acid in the medium and the choice of solvent, and they are negatively affected by water. Kinetic data have been collected for various substrates, and the synthetic benefits of the adjusted reaction conditions are showcased. Enhancements of reaction rates are found in comparison to literature procedures. α-Unsaturated fulvenes that were previously difficult to access can now be obtained in good yields.

Synthesis & antitumor activity of new group 3 Metallocene complexes

Caporale, Angelamaria,Palma, Giuseppe,Mariconda, Annaluisa,Del Vecchio, Vitale,Iacopetta, Domenico,Parisi, Ortensia Ilaria,Sinicropi, Maria Stefania,Puoci, Francesco,Arra, Claudio,Longo, Pasquale,Saturnino, Carmela

, (2017/04/10)

The quest for alternative drugs with respect to the well-known cis-platin and its derivatives, which are still used in more than 50% of the treatment regimens for patients suffering from cancer, is highly needed. In this context, organometallic compounds, which are defined as metal complexes containing at least one direct covalent metal-carbon bond, have recently been found to be promising anticancer drug candidates. A series of new metallocene complexes with scandium, yttrium, and neodymium have been prepared and characterized. Some of these compounds show a very interesting anti-proliferative activity in triple negative breast cancer cell line (MDA.MB231) and the non-hormone sensitive prostate cancer cell line (DU145). Moreover, the interaction of some of them with biological membranes, evaluated using liposomes as bio-membrane mimetic model systems, seems to be relevant. The biological activity of these compounds, particularly those based on yttrium, already effective at low concentrations on both cancer cell lines, should be taken into account with regard to new therapeutic approaches in anticancer therapy.

Asymmetric Pentafulvene Carbometalation - Access to Enantiopure Titanocene Dichlorides of Biological Relevance

Cini, Melchior,Bradshaw, Tracey D.,Woodward, Simon,Lewis, William

supporting information, p. 14179 - 14182 (2016/01/25)

Unprecedented asymmetric copper-catalyzed addition of ZnEt2 (ZnBu2) to the exocyclic C=C bond of pentafulvenes C5H4(=CHAr) (Ar=2-MeOPh and related species) results in enantiomerically enriched (up to 93:7 e.r.)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 38068-98-3